Lv12
70 积分 2024-06-23 加入
Sacituzumab govitecan for Chinese patients with recurrent/metastatic cervical cancer: Interim analysis of the phase II basket study EVER-132-003
11天前
已完结
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial
12天前
已完结
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China
12天前
已完结
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
12天前
已完结
Evaluation of efficacy and fertility after nonradical surgical therapy (extra fascial hysterectomy or cone biopsy, with pelvic lymphadenectomy) for stage IA1, IA2, and IB1 cervical cancer (GOG-0278)
12天前
已完结
Fertility-Sparing Treatment in Early-Stage Cervical Adenocarcinoma: Assessing Feasibility and Limitations
15天前
已关闭
Copeptin as a surrogate marker for arginine vasopressin: analytical insights, current utility, and emerging applications
16天前
已完结
Copeptin: Up-to-date diagnostic and prognostic role highlight
16天前
已完结
Anakinra treatment in macrophage activation syndrome: a single center experience and systemic review of literature
17天前
已完结
Recommendation for Immune Prophylaxis of Respiratory Syncytial Virus Infection in Children
23天前
已完结
皖公网安备34019202002308
